CD4 and cancer: Consistent with prior findings in the 4T1 cancer model51, we did not find significant differences in CD4+ or CD8+ TILs levels within the TME (Fig. 7g, h, and Supplementary Fig. 10e), which may be indicative of the diverse array of mature and differentiated cells within this population52.